• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2009; 4(12): e8408.
Published online Dec 22, 2009. doi:  10.1371/journal.pone.0008408
PMCID: PMC2794374

Expression Profiling the Temperature-Dependent Amphibian Response to Infection by Batrachochytrium dendrobatidis

Gustavo Goldman, Editor

Abstract

Amphibians are experiencing a panzootic of unprecedented proportions caused by the emergence of Batrachochytrium dendrobatidis (Bd). However, all species are not equally at risk of infection, and risk is further modified by environmental variables, specifically temperature. In order to understand how, and when, hosts mount a response to Bd we analysed infection dynamics and patterns of gene expression in the model amphibian species Silurana (Xenopus) tropicalis. Mathematical modelling of infection dynamics demonstrate the existence of a temperature-dependent protective response that is largely independent of the intrinsic growth-rate of Bd. Using temporal expression-profiling by microarrays and qRT-PCR, we characterise this response in the main amphibian lymphoid tissue, the spleen. We demonstrate that clearance of Bd at the host-optimal temperature is not clearly associated with an adaptive immune response, but rather is correlated with the induction of components of host innate immunity including the expression of genes that are associated with the production of the antimicrobial skin peptide preprocareulein (PPCP) as well as inflammatory responses. We find that adaptive immunity appears to be lacking at host-optimal temperatures. This suggests that either Bd does not stimulate, or suppresses, adaptive immunity, or that trade-offs exist between innate and adaptive limbs of the amphibian immune system. At cold temperatures, S. tropicalis loses the ability to mount a PPCP-based innate response, and instead manifests a more pronounced inflammatory reaction that is characterised by the production of proteases and higher pathogen burdens. This study demonstrates the temperature-dependency of the amphibian response to infection by Bd and indicates the influence that changing climates may exert on the ectothermic host response to pathogens.

Introduction

Amphibians are experiencing a panzootic of unprecedented proportions caused by the emergence of Batrachochytrium dendrobatidis (Bd) [1], [2], [3], [4]. While anthropogenic spread of Bd appears to be driving the global distribution of the pathogen [5], disease and declines are modulated by a complex interaction between environment, host and pathogen-specific factors [6], [7]. Research has identified temperature as a key factor in predicting the spatial occurrence of Bd-related declines [8], [9], and longer-term climate trends appear to drive these patterns of disease by amplifying the growth of Bd at its thermal optimum [6], [7]. However, this model ignores the potential contribution of host immunity. While it is known that amphibian antimicrobial peptides (AMPs) correlate with species survival against Bd [10], [11], it is not known if amphibians mount a specific response against Bd, or to what extent any host response is temperature-dependent. Amphibians are ectotherms, and seasonal temperature variability exerts strong direct effects on their immune system [12]. As a consequence, the susceptibility of amphibians to pathogens is expected to vary between seasons. Across longer temporal scales, global warming is negatively affecting survival of even widespread habitat-generalists such as the common toad Bufo bufo [13]. Therefore, the outcome of infection by Bd is likely to be exacerbated by synergies between short-term temperature-dependent effects on the immunocompetence of animals and longer-term physiological stressors.

Here, we describe the use of mathematical models and post-genomic technologies to identify the pathogen-associated gene expression profiles that a model amphibian species, Silurana (formerly Xenopus) tropicalis, exhibits in response to infection by Bd at different temperatures. We focus on defining the temporal dynamics of infection at two infection time-points, days 7 and 42, and at two temperatures; these temperatures were chosen to reflect the ‘tropical’ environmental norm for S. tropicalis, 26°C, and a lower, non-optimal ‘temperate’ temperature, 18°C. By using these two temperatures, we shifted the animals' environment towards the growth optimum for Bd (in vitro between 17°C and 25°C (Figure 1) [14]. In order to quantify the importance of host immunity and Bd growth-rate at these two different temperatures, we profiled the prevalence and intensity of Bd burdens in frogs over a 42-day infectious time course. By using a simple mathematical model, we estimated the contributions of host-response and Bd-growth to the observed infectious outcomes. In tandem, we investigated variation in the host response by profiling time and temperature-dependent global gene expression profiles in the main lymphopoietic tissues in frogs, the spleen by using microarrays and qRT-PCR transcriptomic strategies. Finally, we compared our data with the recent publication of the S. tropicalis transcriptome-response to Bd exposure at cool (18°C) temperatures [15].

Figure 1
Experimental infection and model outputs.

Results and Discussion

Bd Infection Dynamics

Quantitative Bd-specific PCR shows that the prevalence and intensity of infection peaked in animals at each temperature between days 7 and 26 (Figure 1A & C). This suggested that the frogs were mounting an anti-Bd response in both groups, as animals were exposed to high infections (~106 zoospores per procedure) throughout the course of the experiment; in the absence of a host response levels of infection should climb throughout the lifetime of the experiment. There was a higher prevalence and intensity of infection in iCT (infected Cold Temperature group) compared to iWT (infected Warm Temperature group) frogs throughout the experiment (Figure 1). Fitting a mathematical model of the infection process (Figure 1A) showed that animals in the iWT treatment had approximately a third of the chance of infection per procedure compared with those in the iCT treatment (βiWT = 0.170 and βiCT = 0.451) and, once infected, iWT animals recovered almost five times as fast (γiWT = 0.071 and γiCT = 0.015). After accounting for the greater Bd growth rate at the cooler temperatures, the fit of our model was consistent with iWT frogs clearing zoospores approximately twice as fast as iCT frogs (c iWT = 1.322 and c iCT = 0.646). Modelling prevalence assuming an identical host response in iWT animals as in iCT animals does not fit the observed data well (Figure 1). This finding suggests that iWT frogs mount a more effective immune response to Bd than do iCT frogs.

Overview of Patterns of Differential Gene-Expression

To identify the molecular basis of the host response to Bd infection, we used microarrays to profile gene expression in the cold and warm infected cohorts at days 7 and 42 of infection (see Figure S1 for the experimental design). We focused on the spleen which, in the absence of lymph nodes, is the major lymphoid organ in S. tropicalis. This profiling revealed that there was a robust infection-specific aspect to the global induction of gene expression following exposure to Bd, and this response was both temperature- and time-dependent. From a total of 10,878 probes, following normalization to the controls, 434 genes for the iCT and 492 genes for the iWT groups were differentially regulated throughout the experiment. On day 7, frogs had received two exposures to Bd with the result that the ratio of significantly up-regulated:down-regulated genes (the “up[ratio]down ratio”) in iCT frogs was 133[ratio]95, compared to a ratio in iWT frogs of 96[ratio]88. By day 42, after twelve successive exposures to Bd, iCT frogs showed an up[ratio]down ratio of 105[ratio]81 compared to 71[ratio]121 for iWT frogs. Within these differentially expressed groups of genes, iWT frogs expressed significantly (Student t-test: p<0.01) higher numbers of genes with a fold change >30 (2.3%) and 2.5–1.5 (74%) relative to iCT frogs where fold change ranged between >30 (1.83%) and 2.5–1.5 (56.5%). There was little overlap in expression profiles between these two time-points within groups, even when the stringency of the statistical analysis was reduced to p<0.05; here iCT frogs shared 3.30% of genes between days 7 and 42 and iWT frogs shared 2.62%. This finding shows that both infected groups are changing their expression profiles during the intervening 35 day period to a large degree. Temperature-independent genes that were shared between iCT and iWT groups represented 4.76% of the total expression profiles. Differentially regulated genes (>1.5 fold and p<0.01) in Bd infected groups compared against controls are summarized in Table S1. Principal component analysis (PCA) of gene expression in the spleen (Figure 2B) showed that early (day 7) iCT frogs contributed the most diverse patterns of gene-expression of any group, as well as showing the highest prevalence and intensities of infection (Figure 1). These animals were in ‘double jeopardy’ because they faced both a non-optimal temperature [16], [17] and infection by Bd that is growing close to, or at, its environmental optimum [14], [18].

Figure 2
Microarray results in spleen of S. tropicalis Bd infected.

Differentially-Expressed Genes in ‘Warm Infected’ Frogs

Strikingly, the most highly expressed gene in the spleen of iWT frogs 7 days after Bd exposure was the AMP preprocaerulein type III precursor (PPCP; Figure 2, ,3).3). Microarray analysis showed that this gene was found to be expressed 59 fold change above controls in spleen (Table S1, Figure 3A). The decapeptide caerulein is a principal constituent of the skin secretion of a variety of amphibian species [19], [20], [21] and is the most potent AMP to be secreted by S. tropicalis, with a demonstrated antimicrobial activity against 22 microbial species including Gram-positive bacteria and the fungus Candida albicans [22]. The strong up regulation of the differential PPCP expression observed by the microarrays was further validated by qRT-PCR individually for the spleens of all 52 experimental frogs (WT and CT groups; Figure 3B). Interestingly, expression of PPCP was not detected in spleen, or at low levels, in the control group, and there was no significant induction of this gene in any of the CT groups. qRT-PCR showed that PPCP expression levels were up to 71-fold upregulated in day 7 iWT frogs, confirming our microarray results. These results suggest that PPCP is specifically upregulated by S. tropicalis in response to Bd infection, and that induction only occurred at temperatures that are optimal for the host. Production of PPCP-protein has not previously been observed from tissues other than granular skin glands [23], however further analysis using qRT-PCR of skin-tissue showed no clear evidence of PPCP RNA production (Ribas, unpub. obs.). Furthermore, the recent publication by Rosenblum et al. [15] of the transcriptomic response in the liver and skin of infected S. tropicalis by Bd at 18°C also did not find any expression of AMPs in either of these tissues. Together, these findings raise the interesting and potentially important hypothesis that the spleen could be involved in manufacturing and the subsequent trafficking of this peptide following Bd infection as a first response of the innate system, and that this only occurs early on in infection, and at host-optimal temperatures. However, further work is needed to investigate this hypothesis, including an investigation of the temporal nature of AMP secretion and it's efficacy in the skin against Bd, following infection.

Figure 3
Microarray validation by quantitative RT-PCR for each of the 52 experimental frogs using spleen RNA.

Within the iWT cohort, levels of expression of PPCP had reduced to background by day 42 (Figure 3B) showing a strong temporal dependency in the expression of this gene. The production of AMPs is induced following exposure to various pathogens in other amphibian species, such as Rana esculenta [24], [25]. Pathogen-specific induction of AMPs has been demonstrated for this species, where it was shown that it only synthesises AMPs when microbes (bacteria or fungi) are present [25]. The reduction in PPCP production over time that we observe is possibly correlated with the recurrent nature of our infection regime; frogs were challenged every 4 days with over 106 zoospores and such high levels of infectious assault are likely to exhaust the capacity of these frogs to synthesise, traffic and discharge, PPCP [26]. In addition to PPCP, a second AMP, the Cytastin C precursor peptide, was found to be upregulated by 2.6 fold (Table S1, Figure 2A, ,3a)3a) increasing the evidence of the key role of AMPs in protection of amphibians from pathogens [27]. However, as for the PPCP results described above, it is unclear whether increased expression of this protein in the spleen represents de novo synthesis of this AMP, or rather its presence in the spleen is a consequence of the system-wide trafficking of this precursor peptide.

It is estimated that X. tropicalis genome has around 28,000 genes, therefore the Operon v1.0 S. tropicalis microarray that we use here represents a subset of around 40% of these genes and lacks probes for many of the immune genes involved in the anti-pathogen response. Nevertheless, cluster analysis identified a number of genes with homology to vertebrate genes with known roles in immunity. We identified 50 genes with known immune-associated function, and demonstrate the upregulation of several other genes with suspected roles in vertebrate innate immunity (Figure 2A). Notably, genes encoding cell-surface receptors were upregulated over the first stages of infection, indicating that pathways involved in innate-pathogen recognition are rapidly activated (Figure 2A, ,3A).3A). For example, tumour necrosis factor associated factor (TRAF, 1.5 fold) which interacts directly or indirectly with members of the TNFR superfamily [28], fucose binding lectin (2.3 fold) and leptin receptor (2.1 fold) were rapidly induced after two exposures of Bd. Subsequently, a down regulation of these pathogen-recognition genes were observed at the end of experiment (fucose binding lectin, -36.7 fold). Activation of other inflammatory markers, guanylate binding protein interferon inducible (1,44 fold), calcineurin interleukin (IL) 2 inducible (1,33 fold) and trypsinogen genes, were also observed (Figure 2, Table S1). Expression of these trypsinogen genes were significantly increased after 42 days of exposure, although this effect was not as strong as in animals infected at cold temperatures (Figure 2 and and3B,3B, see below). Genes responsible for hemopoietic stem cell maintenance such as VENTX2 (2.6 fold) and hematopoietic SH2 protein adaptor (1.5 to 26 fold) were also increased at 7 days of infection, suggesting that hematopoietic cell development in the spleen is upregulated as a result of infection [29].

In marked contrast to the upregulation of genes involved in innate immunity, the expression of several genes with roles in the generation of an adaptive immune response were downregulated in the spleen over the experiment. Such genes include the B-cell translocation gene (−1.88 fold, day 7) and the cutaneous T-cell lymphoma associated antigen (−1.69 fold, day 42). The complement factor B, an element of the complement system which bridges the innate and adaptive immunity with a critical importance for the generation of a potent humoral response [30] was also inhibited throughout the infection in iWT frogs (−1.63 fold, day 7 and −3.33 fold, day 42; Table S1, Figure 2A). Our results are in concordance with the findings of Rosenblum et al. [15] where five complement pathway genes were shown to decrease their expression in S. tropicalis liver after Bd infection [15]. In this study, these authors raise the hypothesis that a lack of evidence for an adaptive immune response to Bd both in liver and skin tissues is suggestive of a more complex, perhaps inhibitive, effect of Bd on the immune system. Although more needs to be done to understand the role of specific-immunity in combating Bd infection, our experimental results suggest a central role of the amphibian spleen as an effector of the innate immune system, and support the conclusion that there is little evidence for an active adaptive immune-reaction.

Differentially-Expressed Genes in ‘Cold Infected’ Frogs

Microarray data showed that expression of the AMP PPCP did not occur in iCT frogs (Figure 2A). In order to confirm the lack of the expression of this skin peptide in this group, we individually analysed the expression of PPCP by qRT-PCR. Expression of this gene amongst individual iCT frogs was significantly lower than that found among the iWT group (Figure 3B), validating the microarray findings (Figure 2A). Principal component analysis of gene expression in the spleen (Figure 2B) showed that in particular, the iCT 7 day group had the most divergent transcriptional pattern; this was in concordance with the mathematical model where frogs subjected to non-optimal temperatures presented the highest prevalence and intensities of infection. Among the top 50 highly up-regulated genes in the spleen of Bd infection in the cold group, seven genes corresponded to serine protease transcripts (trypsinogens, chymotrypsin, zymogen and elastases; Figure 2A). Serine protease proteins are involved in several photolytic pathways but are also recognised effectors of the innate immune system and are associated with generalised inflammation [31], [32]. Our analysis showed a large increase in levels of expression from day 7 to day 42 for these genes (19 fold change; Figure 3B) in iCT animals and a similar, but less pronounced effect, was seen in the iWT frogs (Figure 3B). Here, we speculate that iCT frogs are attempting to compensate for their lack of PPCP-production by upregulating the production of serine proteases as a secondary, inflammatory, innate immune response. The production of serine proteases are pro-inflammatory markers as they represent an increase in mast-cell activity and degranulation [33], [34]; this may well provide a protective role as our prevalence data and modelling show that even the iCT frogs are able to control their Bd infections, albeit to a lesser degree than is seen in the iWT groups.

In mammals, inflammatory immune reactions are catalysed by the cross-linking of mast-cells with IgE, and this constitutes the major host-response to mucosal gastrointestinal nematodes [35]. The inverse relationship seen here between PPCP and protease production in animals subjected to cold temperatures suggests that a negative feedback may occur between these two facets of the S. tropicalis innate immune response, i.e. that inflammatory responses and secreted AMPs may be mutually inhibitory. If this is the case, then the reduction of AMP-activity seen in iCT and late-stage iWT animals may be the major factor allowing an upregulation of these inflammatory cell-responses.

Wider Conclusions

We have infected the African Pipid frog S. tropicalis at two temperatures and profiled the group prevalence and intensities of infection over 42 days. This has shown that both frogs held at ‘optimal’ temperatures (iWT; 26°C) and those held at ‘non-optimal’ temperatures (iCT; 18°C) are able to survive very high, repeated, doses of Bd. Profiling infection using qPCR has shown that both groups of frogs manifest an early peak of infection followed by a reduction in prevalence; this suggests that both groups of frogs are clearing infection however that the frogs held at ‘optimal’ temperatures clear their infections faster. We then asked the question ‘does this effect occur due to either the increased growth of Bd at lower temperatures or to more effective host-responses at warmer temperatures?’ We use a simple mathematical model parameterised on measured Bd growth rates at different temperatures to address this question. Our findings show that, while the Bd growth-rates can explain some of the difference between the prevalence of infection between iCT and iWT groups of frogs, the rate of zoospore clearance needs to be far higher for the iWT animals in order to explain our data, even when taking into account the decrease in Bd growth-rates at 26°C (shown as the differences between the ‘blue’ and ‘red’ spots in Figure 1B). This difference in zoospore clearance between the iWT and iCT frogs is shown as the difference g in Figure 1A. As the rate of zoospore clearance is analogous to the effectivity of the host response, these findings suggest that frogs held at ‘optimal’ 26°C temperatures are mounting a response that is able to clear Bd infections.

We then identified the basis of this host response in ‘optimal’ iWT compared to ‘non-optimal’ iCT frogs by profiling the changes in the host transcriptome for early (day 7) and late (day 42) infections in the major amphibian lymphoid tissue, the spleen. Because we were interested in identifying ecologically-relevant effects, we chose to house animals in groups rather than singly. While this prevents our analysis from looking at individual-level effects (our transcriptional-level responses are for the experimental groups pooled between tanks), our results are ecologically relevant as S. tropicalis are colonial in nature and cohabit ponds. Further, a pooling strategy enabled us to extract enough rRNA from these frogs small spleens for direct Cy3/Cy5 labelling; this enabled us to avoid pre-amplifying the RNA using PCR, a process which introduces unknown biases in gene-expression. Recent studies by Kendzidorski et al. [36] have shown that most genes in expression studies are not adversely affected by pooling strategies and that the increase in sample-sizes (52 in this study) outweigh the loss of power in ascertaining individual-level-responses.

Our analyses of the S. tropicalis spleen-transcriptome showed extensive differences between all of our combinations of experimental groups. Because the frogs spleens were pooled between tanks, we removed tank-level effects. Therefore, the residual changes in gene-expression are attributable to our three major variables, ‘infection’, ‘time’ and ‘temperature’; all of which contribute to major changes in expression levels in the S. tropicalis spleen. Despite the complex patterns that we found, we were able to isolate three major signals that discriminated between infected and uninfected animals. These were (1) strong upregulation of innate immune AMP-effectors at host optimal temperatures early in infection, (2) ablation of this response in frogs housed at 18°C and (3) a serine-protease proinflammatory response in both optimal and non-optimally-housed frogs.

One of the great conundrums surrounding the emergence of Bd has been its extraordinarily wide host-range in over 350 species, the greatest seen for any vertebrate pathogen to date ([37]; www.spatialepidemiology.net/bd-maps). It has long been suspected that this wide distribution may result from the ability of the pathogen to manipulate and subvert host-immunity or to avoid detection. Recent data by Rosenblum et al. [15] have provided important experimental evidence for this hypothesis by showing that several genes that are associated with immune functions, such as toll-like pathogen receptors and complement-pathway genes, are downregulated in infected S. tropicalis. Our data also support this hypothesis by showing that putative markers of B-cell, T-cell and complement factors are downregulated in the spleens of animals that have been infected at host-optimal 26°C temperatures. Unfortunately, a full comparison between ours, and Rosenblum et al.'s studies is not possible due to the limited gene-set (40%) that are represented on the Operon AROS microarrays that we have used, preventing effective cross-comparisons. However, recent unpublished data targeting a wider panel of adaptive immune-markers in the S. tropicalis liver by qPCR confirm our general findings by showing that these markers are all downregulated in infected frogs at host-optimal temperatures (Seidel, Ribas & Fisher, unpub. data). Taken together, these observations stemming from independent studies by different research groups are broadly concordant in their conclusion that there is a generalised down regulation in markers of adaptive immunity in S. tropicalis following infection by Bd.

Work on another class of eukaryotic pathogens exhibiting wide host ranges, the helminths, has shown that these parasites exhibit widespread subversion of host immunity; strategies include skewing the host response towards a tolerogenic TH2 responses, interference with antigen-processing and modulation of antigen-presenting cells [35]. Interestingly, the final two processes are thought to be modulated by nematode homologues of mammalian cystatins, which function to maintain mammalian dendritic cells in their immature state in order to downregulate antigen presentation [38]. In this study we found that the cystastin C precursor peptide was upregulated in iWT frogs when Bd burdens were highest (at day 7), suggesting that a modulation of host immunity by this mechanism may be occurring. Searching the Bd genome for close homologues of vertebrate proteins with known roles in immune evasion and down-regulation of host immune responses should provide a fruitful approach to identifying whether these specific virulence factors occur. If found, such virulence factors would provide evidence that a long co-evolutionary history has occurred between Bd and its Pipid hosts [39], [40]; this is predicted by the ‘Out of Africa’ hypothesis advocated by Weldon et al. accounting for the global spread of this pathogen owing to the international trade in Pipid species [41].

It is not clear from our study why markers of adaptive immunity are downregulated in iWT frogs. However, down regulation of S. tropicalis' adaptive immunity may be a consequence of the route of infection (cutaneous) and the primary immunity (AMP-mediated and inflammatory innate immunity). The clearest finding from our study was that the most over-expressed transcript (up to x70 fold) was associated with an innate-effector AMP. The various arms of the vertebrate immune response are interdependent, and the upregulation of one arm has extensive effects on the expression of other immune modes; the TH1/TH2 inhibitory dicotomy is a well known example of this effect. It may be that over-expression of AMPs has a dampening effect on other limbs of the amphibian immune-system, resulting in under-expression of adaptive-immune effectors. However, it is perhaps naïve to expect that the effects that we are describing here can be captured by simple ‘innate versus adaptive’ models, and a systematic network analysis of S. tropicalis interactomes on an individual basis is required to dissect these interactions [42]. Recently reported preliminary results demonstrating the development of high-titer antibodies to Bd in Xenopus laevis injected with the heat-killed pathogen and subsequently exposed to live zoospores [43], suggest that Pipids are able to make anti-Bd antibodies. In this case, then the route of infection is likely to be important in determining what sort of host response is manifested. Importantly, our data show that, owing to the lack of a strong adaptive immune response but high innate response, it is unlikely that S. tropicalis can be primed to respond to subsequent challenges of Bd by using a cutaneous method of infection; we suggest that it will not be easy to develop vaccines against Bd and it is unlikely that wild populations will acquire a natural immunity to the pathogen.

Mathematical modelling of the dynamics of infection in our experimental treatments has shown that frogs maintained below their temperature optimum reduce the generation of a successful anti-Bd response, resulting in higher infectious burdens. Analysis of the iCT versus control CT and iWT animals suggests that this may be due to a lack of AMP production; there was no expression of PPCP in the iCT frogs. This may explain why Rosenblum et al. found no evidence of AMP upregulation in their whole-genome arrays as, in their experimental design, all frogs were housed at 18°C; these conditions correspond to our iCT group which was not found to express markers of AMP activity. These findings are likely to be ecologically relevant as it has been shown that, in the field, immunity is temperature-dependent and forced by seasonal patterns. For example seasonal surveys of adult Red spotted newts (Notophthalmus viridescens) by Raffel et al [12] showed a spring lag effect in lymphocyte levels and strong seasonal acclimatization of lymphocyte, neutrophil and eosinophil levels in the autumn. A body of work now exists on the prerequisite of a successful AMP-response to manifest resistance to chytridiomycosis at the species level [18], [44], [45]. Taken together, these studies suggest that factors that influence AMP production are likely to change whether populations/species are refractory to chytridiomycosis, or whether they succumb. It is important to note that there is an apparent association between declines of species and altitude, with populations at higher altitudes suffering greater losses and extinction rates [6], [46]. There is now a clear need for such field-based immunological studies among infected populations to investigate the importance of the host response in the epidemiological triad (host, Bd and the environment). Such studies will quantify the influence that changing climates are able to exert on the ectothermic host response to this devastating emerging pathogen.

Materials and Methods

Ethics Statement

All experiments involving amphibians were conducted under Licence from the British Home Office following the Animals (Scientific Procedures) Act of 1986. Welfare of the amphibians followed the principles of the 3R's; reduction, refinement and replacement and were overseen by a named Veterinarian as well as Animal Care and Welfare Officers. All experiments were preceded by full ethical review by the Imperial College Ethical Review Committee and the British Home Office, and were fully approved by these two organisations.

Silurana tropicalis Infection and Temperature Model

52 adult female frogs of the species S. tropicalis (average weight 12.6 g) were reared in 8 water tanks (3–4 frogs per tank) in temperature-controlled rooms stabilised at 18°C, cold temperature group (CT) or 26°C warm temperature group (WT); Figure S1. Frogs were infected with Bd by individual exposures to 106 Bd zoospores in a 100 ml bath for 3 hours (these groups are designated iCT or iWT). Bd strain IA042 passage 10 was isolated from infected Alytes obstetricans in the Pyrenees, Spain and cultured in ThGL liquid media; zoospore inocula were standardised by counting motile zoospores using a haemocytometer. Isolate IA042 is known to have high virulence from previous experiments [39]. Exposures were repeated twice a week for 7 or 42 days (iCT7, iCT42, iWT7, iWT42). Control animals were similarly treated with regular transfer to an experimental bath, but were exposed to ThGL medium as a sham-infection (groups CT7, CT42, WT7, WT42). Animal welfare was checked daily while feeding and equal amounts of food given to all groups. We observed no sign of illness beyond skin-sloughing early on in the experimental regime, and no mortality occurred. Throughout the experiment, dermal swabs were taken (days 0, 7, 26 and 42) from each animal and infection monitored by a Bd-specific TaqMan Assay (Boyle et al. 2004) (Figure S1). In order to ensure that we were working with a Bd–free colony, frogs were swabbed and tested prior to starting the experiment and were all found to be negative. At days 7 and 42, animals were euthanized by ten-minute exposure to an overdose of MS-222 before the spleen from each animal was rapidly dissected on ice and placed into RNAlater (Qiagen), then kept at −80°C until further transcriptomic analysis (microarray & qRT-PCR).

Bd Dynamics and Mathematic Modelling

The prevalence and intensities of infection were estimated using a qPCR Taqman assay [47]. Briefly, Bd DNA was extracted from swabs and a TaqMan-probe assay used in an Applied Biosystems 7300 Sequence Detection System. Samples were prepared in duplicate with negative controls, and a standard curve was used to quantify the number of Bd zoospore genomic equivalents. The observed prevalence of infection are shown in Figure 1A.

In order to dissect the relative importance of host immunity versus Bd growth-rates, a mathematical model of the experiment was created assuming a constant rate of clearance of infection, and infection only at infection procedures. The model splits the experimental animals into three categories: Susceptible (S), Infected (I) and Recovered (R). All animals begin in the Susceptible category, from which they move into the Infected category at βS animals per infection procedure (which occurred bi-weekly). Infected animals then recover into the Recovered category at rate γI (such that the time spent infected is exponentially distributed.). The equations for the model are given below.

equation image
(1)
equation image
(2)
equation image
(3)

where β is the rate of infection per procedure, γ is the recovery rate once infected, and * indicates a change at a single time point.

This model makes two major assumptions: that the chance of infection via transmission from an infected animal is negligible compared to the chance of being infected by a procedure; and that once an animal recovers it now has either, or a combination of, such a low chance of infection that it will now no longer be infected, or such a fast rate of recovery that if infected it will clear zoospores fast enough that it will show up as negative when tested for infection – i.e. once recovered, animals will stay in the Recovered category. Transmission is assumed to be negligible compared to infection by procedure as the highest intensity of infection reported from any animal was 15.12 zoospore genomic equivalents, whereas each procedure exposed the animals to 106 zoospores, an amount several magnitudes greater than any possible exposure from other animals. To test whether reinfection can be assumed to be negligible, a model was created in which animals in the Recovered compartment were allowed to become reinfected, with different infection and recovery rates to that of newly infected animals. Fitting this model to the prevalence data gave a greatly reduced rate of infection and increased rate of recovery for re-infected recovered animals, supporting the assumption.

The average infected lifespan (T) for both iCT (infected 18°C) and iWT (infected 26°C) animals was calculated from the infection model as the inverse of γ. In order to discern whether differences in infected lifespan between the two models can be explained entirely by differences in Bd growth-rate, or whether a differing host response at each temperature was required, the host response necessary at each temperature in order to return the zoospore count to 0.1 genome-equivalents (the amount above which infection is indicated) at the end of the average infected lifespan was then calculated. This was done by assuming Bd growth within the host is exponential, with a rate determined by two opposing factors: the intrinsic exponential growth of Bd at that temperature (r), and the rate of zoospore clearing by the host (c). To determine r the daily exponential growth rate of Bd in culture was calculated for each temperature [48] and then fitted to a third order polynomial equation (Figure 1B) from which r was calculated for both experimental temperatures. As so little is known about the immune response of S. tropicalis to fungal infections, the simplest form possible for the rate of clearing zoospores has been assumed, with c remaining constant and acting from the moment of infection. Provided that the exponential growth rate of Bd in culture is comparable to the uninhibited growth rate of Bd on the host, and that further infection procedures have no effect on the number of zoospores infecting the host, the required rate of clearing can then be calculated using the equation Ze(r−c)T = 0.1, where Z is the number of zoospores initially infecting the host, and has been assumed to be directly proportional to the rate of infection and the number of zoospores used per procedure. The values of c for both warm and cold experiments were then compared. Mathematical models were fitted to infection dynamics using Berkeley Madonna 8.3.14.

Microarray Hybridization and Transcriptomic Analysis

RNA samples from all spleen tissues were individually prepared (n = 52) using Qiagen RNeasy Mini Kit Columns (Qiagen) and further treated with DNaseI (Invitrogen). RNA quality and quantity was assessed using Bioanalyzer 2100 with RNA 6000 Nano LabChip Kit (Agilent Technologies) and NanoDrop 1000 Spectrophotometer (NanoDrop Technologies). To achieve enough RNA for direct Cy5 labelling without resorting to PCR pre-amplification, RNA spleens from 2 or 3 animals were pooled to give 3 pools of spleen RNA samples for each group of animals (see Figure S1) following published studies [36]. Samples were pooled between tanks but within experimental groups to remove tank-level effects. Sample (4 µg) of each RNA-pool were labelled using SuperScript III cDNA synthesis kit, oligo d(T) primer (Invitrogen) and Cy5-dCTP (GE Healthcare/Amersham). The resulting products were purified using a QIAquick cleaning kit (Qiagen). In parallel, a universal reference RNA sample was created from the spleen of an outgroup of animals (n = 4), which was further amplified to achieve large quantities using Amino Allyl MessageAmp™ II aRNA Amplification (Ambion). The resulting aRNA was labelled using a Cy3 mono-Reactive Dye Pack (GE Healthcare/Amersham). This Cy3-labelled aRNA was served as an universal reference (see below) to provide consistent slide-to-slide and experiment-to-experiment comparability. The principle and reliability of universal reference system using pooled RNA or amplified RNA were originally described [49], [50].

A total of 24 Xenopus tropicalis V1.0 AROS DNA microarray slides were obtained from Operon Biotechnologies (www.operon.com) and previously described [51]. The array design is available at ArrayExpress (www.ebi.ac.uk) under accession number A-MEXP-1446. Slide hybridization and washing steps were performed according to manufacture's protocol using buffers provided with the kit (Operon Biotechnologies). Each array slide was co-hybridized with one of the Cy5 labelled experimental samples and Cy3 labelled aRNA (universal reference). The resulting slides were scanned using a GenePix 4000B (Axon) microarray scanner and the scanned images were analysed with GenePix Pro6.0 (Axon). Statistical analysis was carried out using Genespring GX 7.3 (Agilent). Background-subtracted spot intensities resulting from hybridisation of Cy5-labeled cDNA derived from experimental RNA (signal channel) were divided by the intensity of the signal derived from Cy3-labeled aRNA (control channel). Log-transformed ratios were normalized by applying the intensity-dependent data analysis technique LOWESS, using 20% of the data for smoothing. Only genes not marked absent by GenePix Pro analysis were included. If the value for the reference channel was less than 10 then a value of 10 was used instead. Data arising from the three pooled biological replicates were combined as follows:

For each gene, the normalized log-transformed ratio arising from samples harvested from the infection group kept at 26°C for 7 days (iWT7) was re-normalized to the median value, as was that arising from uninfected group kept at 26°C for 7 days (cWT7). These were combined to give a ratio iWT7/cWT7. Likewise, the ratio were also generated for iWT42/cWT42, iCT7/cCT7 and iCT42/cCT42, representing experimental groups conditioned at 26°C for 7 days, at 18°C for 7 days and 18°C for 42 days, respectively. Differentially expressed genes were identified as genes showing more than 1.5-fold up- or down-regulation (p≤0.01) using a Student t-test in GeneSpring. Fully annotated microarray data have been deposited under ArrayExpress accession number E-MEXP-1936. Expression values are shown in Table S1.

Microarray Validation

Microarray-based gene expression patterns were confirmed for a subset of 10 genes (Figure 3A, Table S2) with known or suspected roles in immunity, by using qRT-PCR. In order to maximise the power of our data, individual analyses were run for each of the experimental frogs. A total of 52 individual spleen RNA samples, 12 for control (CT, WT) and 14 for infected animals (iCT, iWT) for each treatment group (7 and 42 days), were reverse-transcribed using SuperScript III and oligo d(T) (Invitrogen). The resulting cDNA were used as templates in qRT-PCR run in Applied Biosystem 7100 as following: Cycle 1; 50°C 2 min., Cycle 2; 95°C 10 min., Cycle 3; 95°C 15 sec., 60°C 1 min for 40 times. Samples were run as triplicates, with water and RNA as negative controls. All expression values were normalised against the constitutively-expressed gene, elongation factor α. Relative gene expression levels for these qRT-PCR results were analysed using the 2−ΔΔCT method [52] showing log2 Relative Quantification versus the control (iWT7/cWT7, iWT42/cWT42, iCT7/cCT7 and iCT42/cCT42) ± Standard Error.

Further gene expression analysis was performed in order to assess the reliability of the transcriptomics results, for two target genes of interest; the skin peptide PPCP and the serine-protease trypsinogen 2. These two genes were individually tested by qRT-PCR from the spleen RNA all 52 experimental frogs prior to pooling. Statistical analyses of the Relative Quantification results were completed using the Student t-test in the R-Software Package.

The subset of validated genes were (Table S2): muscle specific gene (Xt_10001800), trypsinogen 2 (Xt_10000537), T-cell (Xt_10005209), CD82 antigen (Xt_10002930), TRAF (Xt_10007227), Preprocaerulein type III precursor (Xt_10003079), epithelial membrane protein 2 (Xt_10006495), cystatin C precursor (Xt_10001311), BCL2/adenovirus (Xt_10007462) and protein EST EC2BBA27CH07 (Xt_10007462).

Supporting Information

Figure S1

Schematic of the experimental design. Frogs were infected with Bd by individual exposures to 106 Bd zoospores in a 100 ml bath for 3 hours (iCT or iWT). These exposures were repeated twice a week for 7 or 42 days (iCT7, iCT42, iWT7, iWT42). Control animals were similarly treated with regular transfer to an experimental bath, but exposed to ThGL medium as a sham-infection (CT7, CT42, WT7, WT42). Throughout the experiment, dermal swabs were collected from each animal and infection monitored by Bd-specific TaqMan Assay (*). For transcriptomic analysis RNA was extracted individually from spleen tissues. To achieve enough RNA samples for direct Cy5 labelling without amplification for microarray hybridization, spleen RNA from 2 or 3 animals were pooled to give 3 pools of spleen RNA samples for each animal group. In parallel, a universal reference RNA sample was created from spleen of an out-group animals (n = 4), and was largely amplified aRNA. 3 and 4 microarray slides were used for each experimental group for control and infected treatment respectively (a total of 24 microarray slides). Microarray validation and other transcriptomic analysis were performed by qRT-PCR individually for each animal group of the experiment.

(0.55 MB TIF)

Table S1

Expression values of the microarray results in spleen of animals Bd infected after 7 or 42 days. For statistical analysis, see the Materials and Methods section of the manuscript. Fully annotated microarray data have been deposited under ArrayExpress with accession number E-MEXP-1936.

(0.18 MB XLS)

Table S2

Primer information for the genes used in validating the microarray analysis.

(0.05 MB PDF)

Acknowledgments

We thank Professor Charles R. Bangham for comments on experimental design and the manuscript.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This study was funded by United Kingdom Biotechnology and Biological Research Council (BBSRC) grant BB/E0232071 and United Kingdom Natural Environmental Research Council (NERC) grant NE/E006701/1 to MCF and TWJG, a Royal Society grant to MCF, a George John and Sheilah Livanos Charitable Trust grant to MSL, and National Institutes of Health (NIH) grant R24-AI-059830 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Stuart SN, Chanson JS, Cox NA, Young BE, Rodrigues AS, et al. Status and trends of amphibian declines and extinctions worldwide. Science. 2004;306:1783–1786. [PubMed]
2. Berger L, Speare R, Daszak P, Green DE, Cunningham AA, et al. Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America. Proc Natl Acad Sci U S A. 1998;95:9031–9036. [PMC free article] [PubMed]
3. Gewin V. Riders of a modern-day Ark. PLoS Biol. 2008;6:e24. [PMC free article] [PubMed]
4. Rovito SM, Parra-Olea G, Vasquez-Almazan CR, Papenfuss TJ, Wake DB. Dramatic declines in neotropical salamander populations are an important part of the global amphibian crisis. Proc Natl Acad Sci U S A. 2009;106:3231–3236. [PMC free article] [PubMed]
5. Fisher MC, Garner TW. The relationship between the emergence of Batrachochytrium dendrobatidis, the international trade in amphibians and introduced amphibian species. Fungal Biology Reviews. 2007;21:2–9.
6. Pounds JA, Bustamante MR, Coloma LA, Consuegra JA, Fogden MP, et al. Widespread amphibian extinctions from epidemic disease driven by global warming. Nature. 2006;439:161–167. [PubMed]
7. Bosch J, Carrascal LM, Duran L, Walker S, Fisher MC. Climate change and outbreaks of amphibian chytridiomycosis in a montane area of Central Spain; is there a link? Proc Biol Sci. 2007;274:253–260. [PMC free article] [PubMed]
8. Kriger KM, Hero JM. Large-scale seasonal variation in the prevalence and severity of chytridiomycosis. Journal of Zoology. 2007;271:352–359.
9. Muths E, Pilliodb DS, Livoc LJ. Distribution and environmental limitations of an amphibian pathogen in the Rocky Mountains, USA. Biological Conservation. 2008;141:1484–1492.
10. Rollins-Smith LA, Conlon JM. Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations. Dev Comp Immunol. 2005;29:589–598. [PubMed]
11. Woodhams DC, Ardipradja K, Alford RA, Marantelli G, Reinert LK, et al. Resistance to chytridiomycosis varies among amphibian species and is correlated with skin peptide defenses Animal Conservation. 2007;10:409–417.
12. Raffel TR, Rohr JR, Kiesecker JM, Hudson PJ. Negative effects of changing temperature on amphibian immunity under field conditions. Functional Ecology. 2006;20:819–828.
13. Reading CJ. Linking global warming to amphibian declines through its effects on female body condition and survivorship. Oecologia. 2007;151:125–131. [PubMed]
14. Piotrowski JS, Annis SL, Longcore JE. Physiology of Batrachochytrium dendrobatidis, a chytrid pathogen of amphibians. Mycologia. 2004;96:9–15. [PubMed]
15. Rosenblum EB, Poorten TJ, Settles M, Murdoch GK, Robert J, et al. Genome-wide transcriptional response of Silurana (Xenopus) tropicalis to infection with the deadly chytrid fungus. PLoS One. 2009;4:e6494. [PMC free article] [PubMed]
16. Cooper EL, Wright RK, Klempau AE, Smith CT. Hibernation alters the frog's immune system. Cryobiology. 1992;29:616–631. [PubMed]
17. Maniero GD, Carey C. Changes in selected aspects of immune function in the leopard frog, Rana pipiens, associated with exposure to cold. Journal of Comparative Physiology B-Biochemical Systemic and Environmental Physiology. 1997;167:256–263. [PubMed]
18. Woodhams DC, Alford RA, Briggs CJ, Johnson M, Rollins-Smith L. Life-history trade-offs influence disease in changing climates: strategies of an amphibian pathogen. Ecology. 2008;89:1627–1639. [PubMed]
19. Erspamer V, Erspamer GF, Mazzanti G, Endean R. Active peptides in the skins of one hundred amphibian species from Australia and Papua New Guinea. Comp Biochem Physiol C. 1984;77:99–108. [PubMed]
20. Erspamer V. Half a century of comparative research on biogenic amines and active peptides in amphibian skin and molluscan tissues. Comp Biochem Physiol C. 1984;79:1–7. [PubMed]
21. Brevins CL, Zasloff MA. Peptides from frog skin. Annu Rev Biochem. 1990;59:395–414. [PubMed]
22. Ali MF, Soto A, Knoop FC, Conlon JM. Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim Biophys Acta. 2001;1550:81–89. [PubMed]
23. Seki T, Kikuyama S, Yanaihara N. Development of Xenopus laevis skin glands producing 5-hydroxytryptamine and caerulein. Cell Tissue Res. 1989;258:483–489. [PubMed]
24. Simmaco M, Mangoni ML, Boman A, Barra D, Boman HG. Experimental infections of Rana esculenta with Aeromonas hydrophila: a molecular mechanism for the control of the normal flora. Scand J Immunol. 1998;48:357–363. [PubMed]
25. Mangoni ML, Miele R, Renda TG, Barra D, Simmaco M. The synthesis of antimicrobial peptides in the skin of Rana esculenta is stimulated by microorganisms. FASEB J. 2001;15:1431–1432. [PubMed]
26. Tyler MJ, Stone DJM, Bowie JH. A Novel Method for the Release and Collection of Dermal, Glandular Secretions from the Skin of Frogs. Journal of Pharmacological and Toxicological Methods. 1992;28:199–200. [PubMed]
27. Rollins-Smith LA. The role of amphibian antimicrobial peptides in protection of amphibians from pathogens linked to global amphibian declines. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2009;1788:1593–1599. [PubMed]
28. Arron JR, Walsh MC, Choi Y. TRAF-mediated TNFR-family signaling. Curr Protoc Immunol Chapter 11: Unit 11 19D. 2002. [PubMed]
29. Moretti PA, Davidson AJ, Baker E, Lilley B, Zon LI, et al. Molecular cloning of a human Vent-like homeobox gene. Genomics. 2001;76:21–29. [PubMed]
30. Fujita T, Endo Y, Nonaka M. Primitive complement system–recognition and activation. Mol Immunol. 2004;41:103–111. [PubMed]
31. Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol. 1999;65:137–150. [PubMed]
32. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol. 1991;146:1286–1293. [PubMed]
33. Pejler G, Abrink M, Ringvall M, Wernersson S. Mast cell proteases. Advances in Immunology, Vol 95. 2007;95:167–255. [PubMed]
34. Rauter I, Krauth MT, Westritschnig K, Horak F, Flicker S, et al. Mast cell-derived proteases control allergic inflammation through cleavage of IgE. Journal of Allergy and Clinical Immunology. 2008;121:197–202. [PubMed]
35. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: Cellular and molecular mechanisms. Nature Reviews Immunology. 2003;3:733–744. [PubMed]
36. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A. 2005;102:4252–4257. [PMC free article] [PubMed]
37. Fisher MC, Garner TWJ, Walker J. The global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time and host. Annual Review of Microbiology. 2009;63:291–310. [PubMed]
38. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 1998;93:1135–1145. [PubMed]
39. Fisher MC, Bosch J, Yin Z, Stead DA, Walker J, et al. Proteomic and phenotypic profiling of the amphibian pathogen Batrachochytrium dendrobatidis shows that genotype is linked to virulence. Mol Ecol. 2009;18:415–429. [PubMed]
40. Rosenblum EB, Stajich JE, Maddox N, Eisen MB. Global gene expression profiles for life stages of the deadly amphibian pathogen Batrachochytrium dendrobatidis. Proc Natl Acad Sci U S A. 2008;105:17034–17039. [PMC free article] [PubMed]
41. Weldon C, du Preez LH, Hyatt AD, Muller R, Speare R. Origin of the amphibian chytrid fungus. Emerging Infectious Diseases. 2004;10:2100–2105. [PMC free article] [PubMed]
42. Calvano SE, Xiao WZ, Richards DR, Felciano RM, Baker HV, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032–1037. [PubMed]
43. Rollins-Smith LA, Ramsey JP, Reinert LK, Woodhams DC, Livo LJ, et al. Immune defenses of Xenopus laevis against Batrachochytrium dendrobatidis. Front Biosci (Schol Ed) 2009;1:68–91. [PubMed]
44. Rollins-Smith LA, Woodhams DC, Reinert LK, Vredenburg VT, Briggs CJ, et al. Antimicrobial peptide defenses of the mountain yellow-legged frog (Rana muscosa). Developmental and Comparative Immunology. 2006;30:831–842. [PubMed]
45. Woodhams DC, Rollins-Smith LA, Carey C, Reinert L, Tyler MJ, et al. Population trends associated with skin peptide defences against chytridiomycosis in Australian frogs. Oecologia. 2006;146:531–540. [PubMed]
46. Bosch J, Martínez-Solano I, García-París M. Evidence of a chytrid fungus infection involved in the decline of the common midwife toad (Alytes obstetricans) in protected areas of central Spain. Biological Conservation. 2001;97:331–337.
47. Boyle DG, Boyle DB, Olsen V, Morgan JA, Hyatt AD. Rapid quantitative detection of chytridiomycosis (Batrachochytrium dendrobatidis) in amphibian samples using real-time Taqman PCR assay. Dis Aquat Organ. 2004;60:141–148. [PubMed]
48. Piotrowski JS, Annis SL, Longcore JF. Physiology of Batrachochytrium dendrobatidis, a chytrid pathogen of amphibians. Mycologia. 2004;96:9–15. [PubMed]
49. Novoradovskaya N, Whitfield ML, Basehore LS, Novoradovsky A, Pesich R, et al. Universal Reference RNA as a standard for microarray experiments. BMC Genomics. 2004;5:20. [PMC free article] [PubMed]
50. Park PJ, Cao YA, Lee SY, Kim JW, Chang MS, et al. Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference. J Biotechnol. 2004;112:225–245. [PubMed]
51. Graindorge A, Thuret R, Pollet N, Osborne HB, Audic Y. Identification of post-transcriptionally regulated Xenopus tropicalis maternal mRNAs by microarray. Nucleic Acids Res. 2006;34:986–995. [PMC free article] [PubMed]
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...